Angiopoietin ‐2 promotes pathological angiogenesis and is a novel therapeutic target in murine non‐alcoholic fatty liver disease

Hepatology,Volume 0, Issue ja, -Not available-.

Source: Hepatology - September 27, 2018 Category: Internal Medicine Authors: Sander Lefere, Frederique Van de Velde, Anne Hoorens, Sarah Raevens, Sanne Van Campenhout, Astrid Vandierendonck, Sara Neyt, Bert Vandeghinste, Christian Vanhove, Charlotte Debbaut, Xavier Verhelst, Jo van Dorpe, Christophe Van Steenkiste, Ch Source Type: research